{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:05Z","timestamp":1791357425754,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40272-018-0304-2","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:54:00Z","timestamp":1532566440000},"page":"409-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Methadone for Pain Management in Children with Cancer"],"prefix":"10.1007","volume":"20","author":[{"given":"Catherine","family":"Habashy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doralina L.","family":"Anghelescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"issue":"2","key":"304_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0024-3205(94)00937-6","volume":"56","author":"K Kristensen","year":"1994","unstructured":"Kristensen K, Christensen CB, Christrup LL. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 1994;56(2):45\u201350.","journal-title":"Life Sci"},{"issue":"1","key":"304_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","volume":"223","author":"AL Gorman","year":"1997","unstructured":"Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223(1):5\u20138.","journal-title":"Neurosci Lett"},{"issue":"3","key":"304_CR3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0022-3565(25)10630-7","volume":"274","author":"EE Codd","year":"1995","unstructured":"Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274(3):1263\u201370.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"304_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2165\/00003088-198611020-00001","volume":"11","author":"J Sawe","year":"1986","unstructured":"Sawe J. High-dose morphine and methadone in cancer patients: clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986;11(2):87\u2013106.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"304_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","volume":"25","author":"GK Gourlay","year":"1986","unstructured":"Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25(3):297\u2013312.","journal-title":"Pain"},{"issue":"6","key":"304_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","volume":"50","author":"A Ferrari","year":"2004","unstructured":"Ferrari A, Rosario Coccia CP, Bertolini A, Sternieri E. Methadone\u2014metabolism, pharmacokinetics and interactions. Pharmacol Res. 2004;50(6):551\u20139.","journal-title":"Pharmacol Res"},{"issue":"5","key":"304_CR7","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/ALN.0000000000000867","volume":"123","author":"ED Kharasch","year":"2015","unstructured":"Kharasch ED, Regina KJ, Blood J, Friedel C. Methadone pharmacogenetics: CYP2B6 polymorphisms determine plasma concentrations, clearance, and metabolism. Anesthesiology. 2015;123(5):1142\u201353.","journal-title":"Anesthesiology"},{"key":"304_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","volume":"137","author":"MJ Krantz","year":"2002","unstructured":"Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose-methadone. Ann Intern Med. 2002;137:501\u20134.","journal-title":"Ann Intern Med"},{"key":"304_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0304-3959(02)00461-X","volume":"103","author":"PW Walker","year":"2003","unstructured":"Walker PW, Klein D, Kasza L. High dose methadone and ventricular arrhythmias: a report of three cases. Pain. 2003;103:321\u20134.","journal-title":"Pain"},{"issue":"9","key":"304_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2146\/ajhp070392","volume":"66","author":"J Stringer","year":"2009","unstructured":"Stringer J, Welsh C, Tommasello A. Methadone-associated Q-T interval prolongation and torsades de pointes. Am J Health Syst Pharm. 2009;66(9):825\u201333.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"304_CR11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)38234-5","volume":"289","author":"AM Davis","year":"1999","unstructured":"Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-d-aspartate-induced hyperalgesia. J Pharmacol Exp Ther. 1999;289(2):1048\u201353.","journal-title":"J Pharmacol Exp Ther"},{"key":"304_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/jpm.2000.3.49","volume":"3","author":"IL Mancini","year":"2000","unstructured":"Mancini IL, Hanson J, Neumann CM, Bruera E. Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med. 2000;3:49\u201356.","journal-title":"J Palliat Med"},{"issue":"7","key":"304_CR13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1742-1241.2008.01990.x","volume":"63","author":"W Leppert","year":"2009","unstructured":"Leppert W. The role of methadone in cancer pain treatment\u2013a review. Int J Clin Pract. 2009;63(7):1095\u2013109.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"304_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/0192-0561(85)90049-9","volume":"7","author":"E Tubaro","year":"1985","unstructured":"Tubaro E, Avico U, Santiangeli C, Zuccaro P, Cavallo G, Pacifici R, Croce C, Borelli G. Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol. 1985;7(6):865\u201374.","journal-title":"Int J Immunopharmacol"},{"key":"304_CR15","first-page":"1033","volume":"5","author":"R Maneckjee","year":"1994","unstructured":"Maneckjee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 1994;5:1033\u201340.","journal-title":"Cell Growth Differ"},{"key":"304_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.bbadis.2010.07.024","volume":"1802","author":"S Perez-Alvarez","year":"2010","unstructured":"Perez-Alvarez S, Cuenca-Lopez MD, de Mera RM, Puerta E, Karachitos A, Bednarczyk P, Kmita H, Aguirre N, Galindo MF, Jordan J. Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis. Biochim Biophys Acta. 2010;1802:1036\u201347.","journal-title":"Biochim Biophys Acta"},{"key":"304_CR17","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-08-1227","volume":"68","author":"C Friesen","year":"2008","unstructured":"Friesen C, Roscher M, Alt A, Miltner E. Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance. Cancer Res. 2008;68:6059\u201364.","journal-title":"Cancer Res"},{"key":"304_CR18","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.leukres.2011.06.035","volume":"35","author":"A Singh","year":"2011","unstructured":"Singh A, Jayanthan A, Farran A, Elwi AN, Kim SW, Farran P, Narendran A. Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition. Leuk Res. 2011;35:1649\u201357.","journal-title":"Leuk Res"},{"key":"304_CR19","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1038\/onc.2017.211","volume":"36","author":"SM Kang","year":"2017","unstructured":"Kang SM, Rosales JL, Meier-Stephenson V, Kim S, Lee KY, Narendran A. Genome-wide loss-of-function genetic screening identifies opioid receptor \u03bc1 as a key regulator of l-asparaginase resistance in pediatric acute lymphoblastic leukemia. Oncogene. 2017;36:5910\u20133.","journal-title":"Oncogene"},{"issue":"4","key":"304_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/00002508-199812000-00013","volume":"14","author":"Y Shir","year":"1998","unstructured":"Shir Y, Shenkman Z, Shavelson V, Davidson E, Rosen G. Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases. Clin J Pain. 1998;14(4):350\u20133.","journal-title":"Clin J Pain"},{"key":"304_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0885-3924(01)00389-X","volume":"23","author":"R Sabatowski","year":"2002","unstructured":"Sabatowski R, Kasper SM, Radbruch L. Patient controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine. J Pain Symptom Manaeg. 2002;23:3\u20135.","journal-title":"J Pain Symptom Manaeg"},{"issue":"5","key":"304_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3821\/1913-701X(2007)140[298:POMIBA]2.0.CO;2","volume":"140","author":"Lori Bonertz","year":"2007","unstructured":"Bonertz, L, Dyck N, Kantz, V. Provision of methadone infusion by a community pharmacy for a pediatric patient requiring palliative care. Can Pharm J. 2007; 140(5):298\u20139, 333.","journal-title":"Canadian Pharmacists Journal"},{"key":"304_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pbc.21584","volume":"51","author":"D Davies","year":"2008","unstructured":"Davies D, DeVlaming D, Haines C. Methadone analgesia for children with advanced cancer. Pediatr Blood Cancer. 2008;51:393\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"304_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5055\/jom.2011.0076","volume":"7","author":"DL Anghelescu","year":"2011","unstructured":"Anghelescu DL, Faughnan LG, Hankins GM, Ward DA, Oakes LL. Methadone use in children and young adults at a cancer center: a retrospective study. J Opioid Manag. 2011;7(5):353\u201361.","journal-title":"J Opioid Manag"},{"key":"304_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/pbc.25392","volume":"62","author":"VF Rasmussen","year":"2015","unstructured":"Rasmussen VF, Lundberg V, Jespersen TW, Hasle H. Extreme doses of IV methadone for severe pain in two children with cancer. Pedriatr Blood Cancer. 2015;62:1087\u201390.","journal-title":"Pedriatr Blood Cancer"},{"issue":"11","key":"304_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1089\/jpm.2017.0098","volume":"20","author":"K Madden","year":"2017","unstructured":"Madden K, Bruera E. Very-low-dose methadone to treat refractory neuropathic pain in children with cancer. J Palliat Med. 2017;20(11):1280\u20133.","journal-title":"J Palliat Med"},{"issue":"2","key":"304_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5055\/jom.2016.0325","volume":"12","author":"DL Anghelescu","year":"2016","unstructured":"Anghelescu DL, Patel RM, Mahoney DP, Trujillo L, Faughnan LG, Steen BD, Baker JN, Pei D. Methadone prolongs cardiac conduction in young patients with cancer related pain. J Opioid Manag. 2016;12(2):131\u20138.","journal-title":"J Opioid Manag"},{"issue":"11","key":"304_CR28","doi-asserted-by":"publisher","first-page":"e26614","DOI":"10.1002\/pbc.26614","volume":"64","author":"K Madden","year":"2017","unstructured":"Madden K, Park M, Liu D, Bruera E. The frequency of QTc prolongation among pediatric and young adult patients receiving methadone for cancer pain. Pediatr Blood Cancer. 2017;64(11):e26614.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"304_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ppul.22539","volume":"48","author":"LB Amos","year":"2013","unstructured":"Amos LB, D\u2019Andrea LA. Severe central sleep apnea in a child with leukemia on chronic methadone therapy. Pediatr Pulmolol. 2013;48(1):85\u20137.","journal-title":"Pediatr Pulmolol"},{"issue":"10","key":"304_CR30","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/aas.12562","volume":"59","author":"J Gjedsted","year":"2015","unstructured":"Gjedsted J, Dall R. Severe hypoglycemia during methadone escalation in an 8-year-old child. Acta Anaesthesiol Scand. 2015;59(10):1394\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"key":"304_CR31","first-page":"1","volume":"2","author":"AB Nicholsan","year":"2017","unstructured":"Nicholsan AB, Watson GR, Derry S, Wiffen PJ. Methadone for cancer pain (review). Cochrane Database Syst Rev. 2017;2:1\u201331.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"304_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s005200000180","volume":"9","author":"MP Davis","year":"2001","unstructured":"Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9(2):73\u201383.","journal-title":"Support Care Cancer"},{"issue":"2\u20133","key":"304_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3959(96)03286-1","volume":"70","author":"C Ripamonti","year":"1997","unstructured":"Ripamonti C, Zecca E, Bruera B. An update on the clinical use of methadone for cancer pain. Pain. 1997;70(2\u20133):109\u201315.","journal-title":"Pain"},{"issue":"2","key":"304_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2165\/00148581-200911020-00004","volume":"11","author":"B Zernikow","year":"2009","unstructured":"Zernikow B, Mikel E, Craig F, Anderson BJ. Pediatric palliative care: the use of opioids for the management of pain. Pediatr Drugs. 2009;11(2):129\u201351.","journal-title":"Pediatr Drugs"},{"issue":"5","key":"304_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0885-3924(99)00083-4","volume":"18","author":"NA Hagen","year":"1999","unstructured":"Hagen NA, Wasylenko E. Methadone: outpatient titration and monitoring strategies in cancer patients. J Pain Symptom Manage. 1999;18(5):369\u201375.","journal-title":"J Pain Symptom Manage"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-018-0304-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0304-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0304-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T01:29:01Z","timestamp":1751765341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-018-0304-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["304"],"URL":"https:\/\/doi.org\/10.1007\/s40272-018-0304-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"assertion":[{"value":"26 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Catherine Habashy, Erin Springer, Elizabeth A. Hall, and Doralina L. Anghelescu have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding was received for the systematic review or the preparation of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}